• Search Clinical Trials
• Patient Notification Service
• Overview of Clinical Trials
• Volunteering for a Trial
• Understanding Informed Consent
• Post Clinical Trials

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Hematology | Musculoskeletal | Family Medicine
Disease Category: Multiple Myeloma
Location: United States, WV

Trial Information

SNS01-T-001 - Phase 1/2 Open-Label, Multiple-Dose, Dose-Escalation Study to Evaluate the Safety and Tolerability of SNS01-T Administered by Intravenous Infusion in Patients with Relapsed or Refractory Multiple Myeloma

Patient Inclusion Criteria: See www.hsc.wvu.edu/mbrcc/ctru/ for additional information.

Patient Exclusion Criteria: See www.hsc.wvu.edu/mbrcc/ctru/ for additional information.

West Virginia University - Clinical Trials Research Unit
PO Box 9260
Morgantown, WV 26506
Phone: 304-293-7374

View Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.